These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 19274991

  • 1. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR, Mendis S, Weerakoon HS.
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [Abstract] [Full Text] [Related]

  • 2. Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity.
    Figueiredo MS, Pinto BO, Zago MA.
    Acta Haematol; 1989 Dec; 82(3):144-5. PubMed ID: 2510435
    [Abstract] [Full Text] [Related]

  • 3. Dapsone agranulocytosis in a leprosy patient.
    Hiran S, Pande TK, Pani S, Vishwanathan KA.
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [Abstract] [Full Text] [Related]

  • 4. Dapsone-induced agranulocytosis in a patient of leprosy.
    Mishra M, Chhetia R.
    Indian J Dermatol Venereol Leprol; 2006 Sep; 72(6):456-7. PubMed ID: 17179627
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I, Mehta M, Agnihotri N, Dogra S, Ganguly NK.
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatic and haematological adverse reactions associated with the use of multidrug therapy in leprosy--a five year retrospective study.
    Kaluarachchi SI, Fernandopulle BM, Gunawardane BP.
    Indian J Lepr; 2001 Sep; 73(2):121-9. PubMed ID: 11579648
    [Abstract] [Full Text] [Related]

  • 16. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM, Reis AC, De Rezende TM, Borges AS, Ferreira MS, Nishioka SA.
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract] [Full Text] [Related]

  • 17. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
    Sheen YS, Chu CY, Wang SH, Tsai TF.
    J Dermatolog Treat; 2009 Jun; 20(6):340-3. PubMed ID: 19954390
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.